ELRANATAMAB-BCMM

ELRANATAMAB-BCMM was reported 1158 times

ELRANATAMAB-BCMM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 KOEPPE NODULES 2 0.2500
1 BEHAVIOUR DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0714
2 CAMPYLOBACTER BACTERAEMIA 2 0.0667
3 ALLERGIC BRONCHOPULMONARY MYCOSIS 1 0.0588
4 BLOOD BETA-D-GLUCAN POSITIVE 1 0.0385
5 CAMPYLOBACTER COLITIS 3 0.0349
6 MYOCARDITIS BACTERIAL 1 0.0303
7 TRIGEMINAL PALSY 1 0.0217
8 BACTERIAL DIARRHOEA 4 0.0190
9 LUMBOSACRAL RADICULOPATHY 3 0.0186
10 IMMUNOTOXICITY 2 0.0175
11 PLASMA CELL MYELOMA REFRACTORY 20 0.0149
12 NAIL DEFORMATION 1 0.0149
13 PEDAL PULSE DECREASED 1 0.0147
14 LIGHT CHAIN ANALYSIS DECREASED 1 0.0145
15 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 1 0.0139
16 CYTOMEGALOVIRUS INFECTION REACTIVATION 57 0.0129
17 EAR, NOSE AND THROAT INFECTION 1 0.0122
18 PUNCTURE SITE ERYTHEMA 1 0.0116
19 B-CELL LYMPHOMA REFRACTORY 1 0.0112
20 VIRAL UVEITIS 1 0.0103
21 CYTOKINE RELEASE SYNDROME 207 0.0103
22 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 60 0.0101
23 ADENOVIRAL HEPATITIS 2 0.0085
24 ACHROMOBACTER INFECTION 1 0.0083
25 HUMAN RHINOVIRUS TEST POSITIVE 3 0.0080
26 CYTOMEGALOVIRUS ENTEROCOLITIS 6 0.0078
27 IMMUNOGLOBULINS ABNORMAL 2 0.0077
28 HERPES ZOSTER REACTIVATION 2 0.0076
29 ENCEPHALITIS CYTOMEGALOVIRUS 3 0.0068
30 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 1 0.0066
31 PARAPROTEINAEMIA 2 0.0065
32 VARICELLA ZOSTER PNEUMONIA 1 0.0057
33 MENINGOENCEPHALITIS VIRAL 1 0.0056
34 LARYNGEAL OBSTRUCTION 1 0.0055
35 HUMORAL IMMUNE DEFECT 2 0.0054
36 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
37 SUSPECTED OFF LABEL USE 23 0.0051
38 HANGING 1 0.0051
39 SALMONELLA BACTERAEMIA 1 0.0048
40 LIGHT CHAIN ANALYSIS ABNORMAL 1 0.0048
41 IMMOBILISATION SYNDROME 1 0.0047
42 CYTOMEGALOVIRUS GASTROENTERITIS 1 0.0046
43 CARDIOMYOPATHY ACUTE 1 0.0046
44 TUMOUR PSEUDOPROGRESSION 5 0.0046
45 EPIDERMOLYSIS 2 0.0043
46 PERIPHERAL VEIN THROMBOSIS 1 0.0042
47 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
48 HYPOGAMMAGLOBULINAEMIA 26 0.0040
49 NEUTROPHIL PERCENTAGE DECREASED 2 0.0038
50 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
51 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
52 CUTIS LAXA 1 0.0037
53 INTERLEUKIN LEVEL INCREASED 2 0.0036
54 MONOCLONAL IMMUNOGLOBULIN INCREASED 1 0.0035
55 GALLBLADDER OEDEMA 1 0.0034
56 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
57 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
58 ANOREXIA NERVOSA 1 0.0031
59 GASTRIC VARICES HAEMORRHAGE 1 0.0030
60 LIGHT CHAIN ANALYSIS INCREASED 3 0.0029
61 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
62 MONOCYTE PERCENTAGE INCREASED 2 0.0028
63 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 1 0.0028
64 CYTOMEGALOVIRUS VIRAEMIA 12 0.0027
65 CONJUNCTIVAL DISORDER 1 0.0026
66 CYSTITIS VIRAL 1 0.0026
67 BONE MARROW INFILTRATION 1 0.0026
68 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
69 SUPERINFECTION BACTERIAL 2 0.0025
70 PNEUMONIA INFLUENZAL 3 0.0025
71 HERPES ZOSTER DISSEMINATED 2 0.0025
72 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
73 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
74 PSEUDOMONAL BACTERAEMIA 2 0.0023
75 ENTEROVIRUS INFECTION 2 0.0023
76 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
77 IMMUNOGLOBULINS DECREASED 3 0.0022
78 GASTRITIS BACTERIAL 1 0.0021
79 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
80 ECZEMA ASTEATOTIC 1 0.0021
81 BLAST CELLS PRESENT 1 0.0021
82 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 17 0.0021
83 IMMUNE-MEDIATED THYROIDITIS 1 0.0020
84 METASTASES TO BONE MARROW 1 0.0020
85 HERPES ZOSTER OTICUS 1 0.0020
86 ORTHOPAEDIC PROCEDURE 1 0.0019
87 PERTUSSIS 2 0.0019
88 HEPATITIS B REACTIVATION 6 0.0019
89 EYE INFECTION BACTERIAL 1 0.0018
90 T-CELL LYMPHOMA 2 0.0017
91 OPHTHALMIC HERPES SIMPLEX 1 0.0017
92 HAEMATOMA INFECTION 1 0.0017
93 CYTOMEGALOVIRUS INFECTION 28 0.0017
94 SECOND PRIMARY MALIGNANCY 14 0.0017
95 ESCHERICHIA TEST POSITIVE 2 0.0017
96 PLASMA CELL LEUKAEMIA 1 0.0017
97 ENCEPHALITIS VIRAL 2 0.0016
98 MUSCLE ABSCESS 1 0.0016
99 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
100 GLIOMA 1 0.0016
101 PHYSICAL DECONDITIONING 4 0.0016
102 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
103 KLEBSIELLA TEST POSITIVE 1 0.0015
104 CYTOPENIA 18 0.0015
105 TUMOUR FLARE 1 0.0015
106 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
107 INJECTION SITE MACULE 1 0.0015
108 FACIAL DISCOMFORT 1 0.0014
109 VIRAL HAEMORRHAGIC CYSTITIS 1 0.0014
110 PALMOPLANTAR KERATODERMA 1 0.0014
111 BACTERIAL DISEASE CARRIER 1 0.0014
112 CHOLANGITIS ACUTE 1 0.0013
113 BRONCHITIS BACTERIAL 1 0.0013
114 PNEUMONIA PSEUDOMONAL 2 0.0013
115 BLOOD FIBRINOGEN INCREASED 1 0.0013
116 EYELID FUNCTION DISORDER 1 0.0013
117 PNEUMONIA MYCOPLASMAL 1 0.0013
118 VARICELLA 3 0.0013
119 ENTEROCOCCAL SEPSIS 1 0.0012
120 PERONEAL NERVE PALSY 7 0.0012
121 ANAL ULCER 1 0.0012
122 PSEUDOMONAS TEST POSITIVE 1 0.0012
123 HYPOPYON 1 0.0012
124 CAMPYLOBACTER INFECTION 1 0.0012
125 GASTROENTERITIS SALMONELLA 1 0.0012
126 HYPERPYREXIA 5 0.0012
127 CRANIOFACIAL FRACTURE 1 0.0012
128 PLASMA CELL MYELOMA 45 0.0012
129 AXONAL NEUROPATHY 1 0.0011
130 PSEUDOMONAL SEPSIS 2 0.0011
131 INJECTION SITE DRYNESS 1 0.0011
132 OROPHARYNGEAL CANDIDIASIS 1 0.0011
133 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0011
134 ADENOCARCINOMA GASTRIC 1 0.0011
135 PLASMACYTOMA 2 0.0011
136 CEREBRAL TOXOPLASMOSIS 1 0.0011
137 PERFORMANCE STATUS DECREASED 5 0.0011
138 INTRACRANIAL MASS 1 0.0011
139 RHINOVIRUS INFECTION 4 0.0010
140 MASTOIDITIS 1 0.0010
141 DROWNING 1 0.0010
142 CAPILLARY LEAK SYNDROME 2 0.0010
143 BLAST CELL COUNT INCREASED 1 0.0010
144 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
145 INNER EAR DISORDER 1 0.0009
146 PRODUCT SELECTION ERROR 1 0.0009
147 OCULAR TOXICITY 1 0.0009
148 ESSENTIAL TREMOR 1 0.0009
149 VITH NERVE PARALYSIS 1 0.0009
150 BLOOD FIBRINOGEN DECREASED 1 0.0009
151 INFECTION REACTIVATION 1 0.0009
152 CYTOMEGALOVIRUS COLITIS 2 0.0009
153 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
154 SYSTEMIC MYCOSIS 1 0.0009
155 LIP ULCERATION 1 0.0009
156 PROCALCITONIN INCREASED 1 0.0009
157 FEBRILE INFECTION 1 0.0008
158 MALIGNANT NEOPLASM PROGRESSION 87 0.0008
159 RETINAL VASCULITIS 1 0.0008
160 RECTAL PROLAPSE 1 0.0008
161 CLOSTRIDIUM COLITIS 1 0.0008
162 UVEITIS 11 0.0008
163 XEROSIS 1 0.0008
164 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
165 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
166 PROTEIN TOTAL DECREASED 3 0.0008
167 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
168 TUMOUR LYSIS SYNDROME 7 0.0008
169 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
170 RETINAL ARTERY OCCLUSION 2 0.0008
171 PLATELET TRANSFUSION 1 0.0008
172 NAIL DISCOLOURATION 3 0.0008
173 PNEUMONIA FUNGAL 3 0.0008
174 HERPES OPHTHALMIC 1 0.0008
175 CORONAVIRUS INFECTION 5 0.0008
176 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
177 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
178 MENINGITIS VIRAL 1 0.0007
179 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
180 PRERENAL FAILURE 1 0.0007
181 BLOOD ELECTROLYTES DECREASED 1 0.0007
182 MENINGITIS BACTERIAL 1 0.0007
183 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
184 NEOPLASM PROGRESSION 24 0.0007
185 ESCHERICHIA SEPSIS 2 0.0007
186 ADENOVIRUS INFECTION 2 0.0007
187 NEUROTOXICITY 12 0.0007
188 CONJUNCTIVITIS ALLERGIC 1 0.0007
189 INFUSION SITE REACTION 2 0.0007
190 GASTRITIS HAEMORRHAGIC 1 0.0007
191 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
192 GASTROSTOMY 1 0.0006
193 FULL BLOOD COUNT DECREASED 13 0.0006
194 PHARYNGEAL PARAESTHESIA 1 0.0006
195 BILE DUCT STONE 2 0.0006
196 PNEUMONIA VIRAL 2 0.0006
197 PAPILLOMA VIRAL INFECTION 1 0.0006
198 OTITIS MEDIA 2 0.0006
199 ORGANISING PNEUMONIA 3 0.0006
200 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
201 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
202 SALMONELLOSIS 1 0.0006
203 NEOPLASM RECURRENCE 2 0.0006
204 PSEUDOMONAS INFECTION 5 0.0006
205 INJECTION SITE OEDEMA 1 0.0006
206 RETINITIS 1 0.0006
207 BLOOD CREATININE ABNORMAL 2 0.0006
208 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
209 VASCULAR PSEUDOANEURYSM 1 0.0006
210 NECROTISING FASCIITIS 2 0.0006
211 COMPRESSION FRACTURE 3 0.0006
212 VOCAL CORD PARALYSIS 1 0.0006
213 SOFT TISSUE INFECTION 1 0.0005
214 OPPORTUNISTIC INFECTION 1 0.0005
215 PUPILLARY REFLEX IMPAIRED 1 0.0005
216 INJECTION SITE CELLULITIS 1 0.0005
217 ACCIDENTAL DEATH 1 0.0005
218 LEUKOENCEPHALOPATHY 2 0.0005
219 NASAL OBSTRUCTION 1 0.0005
220 SKIN TOXICITY 3 0.0005
221 DIPLEGIA 1 0.0005
222 ORGAN FAILURE 2 0.0005
223 PERIPHERAL ISCHAEMIA 2 0.0005
224 CHOLANGITIS SCLEROSING 1 0.0005
225 CHEST INJURY 1 0.0005
226 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
227 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
228 FACIAL PARALYSIS 4 0.0005
229 RADIATION PNEUMONITIS 1 0.0005
230 CD4 LYMPHOCYTES DECREASED 1 0.0005
231 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
232 TENDON DISORDER 3 0.0005
233 LARGE INTESTINAL OBSTRUCTION 1 0.0004
234 CALCINOSIS 1 0.0004
235 PNEUMONIA BACTERIAL 4 0.0004
236 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
237 FLAT AFFECT 1 0.0004
238 PATELLA FRACTURE 1 0.0004
239 BILIRUBIN CONJUGATED INCREASED 1 0.0004
240 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
241 PUSTULE 1 0.0004
242 NEUTROPHIL COUNT DECREASED 17 0.0004
243 HUMERUS FRACTURE 2 0.0004
244 GUILLAIN-BARRE SYNDROME 2 0.0004
245 C-REACTIVE PROTEIN INCREASED 15 0.0004
246 HAEMATOLOGICAL INFECTION 1 0.0004
247 EYE OEDEMA 1 0.0004
248 SUFFOCATION FEELING 1 0.0004
249 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
250 DERMATITIS EXFOLIATIVE 2 0.0004
251 TOXIC SKIN ERUPTION 4 0.0004
252 LYMPHOCYTE COUNT DECREASED 7 0.0004
253 HEPATIC CYTOLYSIS 5 0.0004
254 ABDOMINAL INFECTION 1 0.0004
255 CANCER PAIN 1 0.0004
256 INJECTION SITE RASH 12 0.0004
257 FEMORAL NECK FRACTURE 2 0.0004
258 MEAN CELL VOLUME INCREASED 1 0.0004
259 VENTRICULAR DYSFUNCTION 1 0.0004
260 EXFOLIATIVE RASH 1 0.0004
261 RADICULOPATHY 1 0.0004
262 LUNG OPACITY 1 0.0004
263 POST PROCEDURAL INFECTION 3 0.0004
264 SEPTIC SHOCK 16 0.0004
265 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
266 NEUTROPHIL COUNT ABNORMAL 1 0.0004
267 NEUROLOGICAL SYMPTOM 2 0.0003
268 PARAPLEGIA 1 0.0003
269 SKIN WARM 2 0.0003
270 SKIN EXFOLIATION 29 0.0003
271 COVID-19 PNEUMONIA 4 0.0003
272 BACTERAEMIA 4 0.0003
273 HEPATITIS FULMINANT 1 0.0003
274 IMMUNODEFICIENCY 5 0.0003
275 HEPATITIS B 2 0.0003
276 CHOLANGITIS 2 0.0003
277 INJECTION SITE HYPERSENSITIVITY 1 0.0003
278 BRAIN OEDEMA 4 0.0003
279 INJECTION SITE IRRITATION 4 0.0003
280 PLASMA CELL MYELOMA RECURRENT 1 0.0003
281 HEPATITIS ACUTE 2 0.0003
282 BACTERIAL SEPSIS 1 0.0003
283 ASPERGILLUS INFECTION 2 0.0003
284 DEAFNESS NEUROSENSORY 1 0.0003
285 INFECTION 44 0.0003
286 LISTLESS 1 0.0003
287 IMMUNE SYSTEM DISORDER 4 0.0003
288 SKIN INJURY 1 0.0003
289 LYME DISEASE 1 0.0003
290 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
291 METASTASES TO SPINE 1 0.0003
292 BK VIRUS INFECTION 1 0.0003
293 NEUTROPENIA 40 0.0003
294 NEUTROPHIL COUNT INCREASED 3 0.0003
295 HYPERTRANSAMINASAEMIA 2 0.0003
296 FACIAL PARESIS 1 0.0003
297 MYELOSUPPRESSION 10 0.0003
298 ANOSMIA 4 0.0003
299 ORAL DISORDER 2 0.0003
300 VIRAL INFECTION 9 0.0003
301 HYDRONEPHROSIS 2 0.0003
302 CHRONIC SINUSITIS 1 0.0003
303 APHTHOUS ULCER 2 0.0003
304 EPIGASTRIC DISCOMFORT 1 0.0003
305 BLOOD ALBUMIN DECREASED 2 0.0003
306 POLYNEUROPATHY 3 0.0003
307 AZOTAEMIA 1 0.0003
308 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
309 BLEPHARITIS 1 0.0002
310 ADRENAL INSUFFICIENCY 3 0.0002
311 RECURRENT CANCER 1 0.0002
312 DEMYELINATION 1 0.0002
313 HYPERURICAEMIA 1 0.0002
314 COAGULOPATHY 4 0.0002
315 PYREXIA 82 0.0002
316 MUSCLE FATIGUE 1 0.0002
317 FEBRILE BONE MARROW APLASIA 1 0.0002
318 SHOULDER OPERATION 1 0.0002
319 HEPATIC FAILURE 7 0.0002
320 PYELONEPHRITIS 2 0.0002
321 DELIRIUM 8 0.0002
322 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
323 HYPOXIA 8 0.0002
324 IMMUNOSUPPRESSION 2 0.0002
325 ILEUS PARALYTIC 1 0.0002
326 NEUROPATHY PERIPHERAL 21 0.0002
327 VASCULAR DEVICE INFECTION 1 0.0002
328 UROSEPSIS 2 0.0002
329 HYPOMAGNESAEMIA 3 0.0002
330 SEPSIS 24 0.0002
331 MASS 3 0.0002
332 YELLOW SKIN 1 0.0002
333 FLANK PAIN 2 0.0002
334 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
335 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
336 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
337 SKIN ABRASION 1 0.0002
338 FEBRILE NEUTROPENIA 14 0.0002
339 SPUTUM DISCOLOURED 2 0.0002
340 SARCOIDOSIS 1 0.0002
341 SUBDURAL HAEMATOMA 3 0.0002
342 PARKINSONISM 2 0.0002
343 STAPHYLOCOCCAL SEPSIS 1 0.0002
344 INFLAMMATORY MARKER INCREASED 1 0.0002
345 PNEUMONIA ASPIRATION 5 0.0002
346 ERYSIPELAS 1 0.0002
347 TOXIC ENCEPHALOPATHY 1 0.0002
348 TASTE DISORDER 4 0.0002
349 PATHOLOGICAL FRACTURE 1 0.0002
350 AMMONIA INCREASED 1 0.0002
351 CACHEXIA 1 0.0002
352 VARICOSE VEIN 1 0.0002
353 HYPERBILIRUBINAEMIA 2 0.0002
354 BRAIN FOG 3 0.0002
355 POLYARTHRITIS 1 0.0002
356 SERUM FERRITIN INCREASED 1 0.0002
357 SUDDEN DEATH 2 0.0002
358 INFLUENZA 21 0.0002
359 RASH ERYTHEMATOUS 9 0.0002
360 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
361 GINGIVITIS 1 0.0002
362 BLOOD BILIRUBIN INCREASED 5 0.0002
363 ERYTHEMA OF EYELID 1 0.0002
364 ASPIRATION 2 0.0002
365 PNEUMONIA 59 0.0002
366 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
367 HYPERKERATOSIS 1 0.0002
368 STEVENS-JOHNSON SYNDROME 4 0.0002
369 DEMENTIA 5 0.0002
370 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
371 CHOLECYSTITIS ACUTE 1 0.0002
372 HERPES VIRUS INFECTION 1 0.0002
373 ENTEROCOLITIS 1 0.0002
374 BLOOD URIC ACID INCREASED 1 0.0002
375 ELECTROLYTE IMBALANCE 2 0.0002
376 BRADYKINESIA 1 0.0002
377 PLEURISY 1 0.0002
378 PRODUCTIVE COUGH 8 0.0002
379 ODYNOPHAGIA 1 0.0002
380 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
381 CHILLS 19 0.0002
382 AGEUSIA 4 0.0002
383 NERVOUS SYSTEM DISORDER 5 0.0002
384 OXYGEN SATURATION DECREASED 9 0.0002
385 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
386 SECRETION DISCHARGE 2 0.0002
387 HYPOTENSION 32 0.0002
388 SWELLING OF EYELID 1 0.0002
389 CELLULITIS 8 0.0002
390 HYPOCALCAEMIA 3 0.0002
391 FRACTURE 3 0.0002
392 LIVER DISORDER 7 0.0002
393 HERPES ZOSTER 9 0.0002
394 RESPIRATORY TRACT INFECTION 4 0.0002
395 WALKING AID USER 1 0.0002
396 UPPER LIMB FRACTURE 3 0.0002
397 PLATELET COUNT DECREASED 16 0.0001
398 WRONG PRODUCT ADMINISTERED 1 0.0001
399 PNEUMONITIS 4 0.0001
400 APHONIA 2 0.0001
401 BLOOD TEST ABNORMAL 2 0.0001
402 DECREASED APPETITE 33 0.0001
403 ANAEMIA 27 0.0001
404 HAND FRACTURE 1 0.0001
405 LEUKOPENIA 7 0.0001
406 LIVER FUNCTION TEST INCREASED 3 0.0001
407 MYELODYSPLASTIC SYNDROME 2 0.0001
408 SINUSITIS 14 0.0001
409 MOUTH HAEMORRHAGE 1 0.0001
410 SENSITIVE SKIN 1 0.0001
411 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
412 TRANSAMINASES INCREASED 3 0.0001
413 HEPATOTOXICITY 3 0.0001
414 DEATH 115 0.0001
415 COLITIS 5 0.0001
416 COVID-19 23 0.0001
417 HYPERTHERMIA 1 0.0001
418 RENAL IMPAIRMENT 11 0.0001
419 DEVICE RELATED INFECTION 2 0.0001
420 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
421 LYMPHOMA 2 0.0001
422 MUSCULOSKELETAL CHEST PAIN 2 0.0001
423 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
424 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
425 HAEMOGLOBIN DECREASED 13 0.0001
426 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
427 MIOSIS 1 0.0001
428 RHINITIS 1 0.0001
429 RESPIRATORY FAILURE 9 0.0001
430 BLOOD POTASSIUM INCREASED 2 0.0001
431 SHOCK HAEMORRHAGIC 1 0.0001
432 DECUBITUS ULCER 1 0.0001
433 ASPHYXIA 1 0.0001
434 HICCUPS 1 0.0001
435 HYPERAESTHESIA 1 0.0001
436 ESCHERICHIA INFECTION 1 0.0001
437 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
438 STAPHYLOCOCCAL INFECTION 4 0.0001
439 INJECTION SITE ERYTHEMA 15 0.0001
440 SENSATION OF FOREIGN BODY 1 0.0001
441 BLOOD MAGNESIUM DECREASED 1 0.0001
442 MYOPATHY 1 0.0001
443 SKIN SWELLING 1 0.0001
444 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
445 NAIL DISORDER 1 0.0001
446 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
447 GRIP STRENGTH DECREASED 1 0.0001
448 LUNG INFILTRATION 1 0.0001
449 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
450 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
451 CARDIOTOXICITY 1 0.0001
452 ISCHAEMIC STROKE 2 0.0001
453 CEREBRAL HAEMORRHAGE 4 0.0001
454 HEART RATE INCREASED 11 0.0001
455 RASH PRURITIC 6 0.0001
456 BRAIN NEOPLASM 1 0.0001
457 NERVE COMPRESSION 1 0.0001
458 THROMBOCYTOPENIA 12 0.0001
459 ERYTHEMA MULTIFORME 1 0.0001
460 BLOOD CREATININE INCREASED 7 0.0001
461 LEUKAEMIA 1 0.0001
462 HAEMATOTOXICITY 1 0.0001
463 GASTRIC ULCER 2 0.0001
464 RED BLOOD CELL COUNT DECREASED 3 0.0001
465 BALANCE DISORDER 9 0.0001
466 ACUTE RESPIRATORY FAILURE 2 0.0001
467 SINUS BRADYCARDIA 1 0.0001
468 HERNIA 2 0.0001
469 RASH 45 0.0001
470 BONE PAIN 6 0.0001
471 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
472 DISORIENTATION 4 0.0001
473 HAEMATOCRIT DECREASED 2 0.0001
474 BLOOD POTASSIUM DECREASED 3 0.0001
475 BRAIN INJURY 1 0.0001
476 CARDIAC FAILURE 8 0.0001
477 DRY MOUTH 8 0.0001
478 EYELID PTOSIS 1 0.0001
479 SUBARACHNOID HAEMORRHAGE 1 0.0001
480 MOTOR DYSFUNCTION 1 0.0001
481 BODY TEMPERATURE INCREASED 2 0.0001
482 PRODUCT PREPARATION ERROR 2 0.0001
483 TEMPERATURE INTOLERANCE 1 0.0001
484 EYE DISCHARGE 1 0.0001
485 WEIGHT FLUCTUATION 1 0.0001
486 FULL BLOOD COUNT ABNORMAL 1 0.0001
487 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
488 JOINT INJURY 2 0.0001
489 LACTIC ACIDOSIS 3 0.0001
490 SKIN LACERATION 1 0.0001
491 BACK INJURY 1 0.0001
492 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
493 BLOOD PRESSURE INCREASED 14 0.0001
494 MELAENA 2 0.0001
495 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
496 SKIN DISORDER 3 0.0001
497 SKIN INFECTION 1 0.0001
498 BLOOD CALCIUM DECREASED 1 0.0001
499 EYE INFECTION 1 0.0001
500 STATUS EPILEPTICUS 1 0.0001
501 NEOPLASM 1 0.0001
502 SHOCK 2 0.0001
503 HYPOKALAEMIA 4 0.0001
504 EYELID OEDEMA 1 0.0001
505 HEART RATE DECREASED 3 0.0001
506 NASAL CONGESTION 5 0.0001
507 CHOLECYSTITIS 1 0.0001
508 HYPERLIPIDAEMIA 1 0.0001
509 MUSCLE RIGIDITY 1 0.0001
510 ATRIAL FIBRILLATION 8 0.0001
511 LUNG DISORDER 4 0.0001
512 ENCEPHALOPATHY 2 0.0001
513 CARDIOMEGALY 1 0.0001
514 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
515 HYPERCALCAEMIA 1 0.0001
516 GENERALISED OEDEMA 1 0.0001
517 EYE SWELLING 3 0.0001
518 PHARYNGITIS 1 0.0001
519 MUSCLE ATROPHY 1 0.0001
520 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
521 RHINORRHOEA 5 0.0001
522 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
523 DEAFNESS 2 0.0001
524 TOOTH INFECTION 1 0.0001
525 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
526 SARS-COV-2 TEST POSITIVE 1 0.0001
527 PANCREATITIS 4 0.0001
528 ADVERSE REACTION 1 0.0001
529 EYE HAEMORRHAGE 1 0.0001
530 DRY SKIN 10 0.0001
531 FATIGUE 58 0.0001
532 LIMB INJURY 2 0.0001
533 BLINDNESS 3 0.0001
534 IMPAIRED GASTRIC EMPTYING 1 0.0001
535 ACUTE HEPATIC FAILURE 1 0.0001
536 INJECTION SITE REACTION 5 0.0001
537 RESPIRATORY ARREST 2 0.0001
538 RESPIRATORY DISTRESS 2 0.0001
539 ASTHENIA 27 0.0001
540 HUNGER 1 0.0001
541 CARDIO-RESPIRATORY ARREST 3 0.0001
542 PANCYTOPENIA 4 0.0001
543 HYPERSOMNIA 2 0.0001
544 IMPAIRED QUALITY OF LIFE 1 0.0001
545 PARAESTHESIA ORAL 1 0.0001
546 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
547 MENTAL DISORDER 3 0.0001
548 HYPOKINESIA 1 0.0001
549 GASTROENTERITIS 1 0.0001
550 RENAL FAILURE 9 0.0001
551 TACHYCARDIA 6 0.0001
552 PULMONARY MASS 1 0.0001
553 COLON CANCER 1 0.0001
554 PULMONARY OEDEMA 3 0.0001
555 GASTROINTESTINAL DISORDER 6 0.0001
556 HAEMORRHAGE INTRACRANIAL 1 0.0001
557 HYPOAESTHESIA ORAL 1 0.0001
558 LACRIMATION INCREASED 2 0.0001
559 CHRONIC KIDNEY DISEASE 5 0.0001
560 OEDEMA PERIPHERAL 8 0.0001
561 FEMUR FRACTURE 2 0.0001
562 EJECTION FRACTION DECREASED 1 0.0001
563 COGNITIVE DISORDER 3 0.0001
564 CYANOSIS 1 0.0001
565 COMA 3 0.0001
566 ULCER 1 0.0001
567 SCIATICA 1 0.0001
568 GAIT DISTURBANCE 12 0.0001
569 SENSORY DISTURBANCE 1 0.0001
570 HIP FRACTURE 2 0.0001
571 DIARRHOEA 40 0.0001
572 INTERSTITIAL LUNG DISEASE 3 0.0001
573 MUSCULAR WEAKNESS 7 0.0001
574 DEEP VEIN THROMBOSIS 4 0.0001
575 SWELLING FACE 4 0.0001
576 COUGH 17 0.0001
577 PHOTOSENSITIVITY REACTION 1 0.0001
578 BACK PAIN 14 0.0001
579 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
580 FUNGAL INFECTION 2 0.0001
581 CANDIDA INFECTION 1 0.0001
582 CIRCULATORY COLLAPSE 1 0.0001
583 URINARY TRACT INFECTION 10 0.0001
584 HYPERKALAEMIA 2 0.0001
585 METASTASES TO LIVER 1 0.0001
586 HEAD DISCOMFORT 1 0.0001
587 DRUG ERUPTION 1 0.0001
588 OFF LABEL USE 49 0.0001
589 OEDEMA 3 0.0001
590 LEUKOCYTOSIS 1 0.0001
591 TOOTHACHE 1 0.0001
592 ANAPHYLACTIC REACTION 3 0.0001
593 TREMOR 9 0.0001
594 FALL 18 0.0001
595 BRONCHITIS 4 0.0001
596 CONJUNCTIVITIS 1 0.0001
597 AGRANULOCYTOSIS 1 0.0001
598 BACTERIAL INFECTION 1 0.0001
599 HEPATIC FUNCTION ABNORMAL 2 0.0001
600 HEPATIC CIRRHOSIS 1 0.0001
601 DYSPNOEA EXERTIONAL 2 0.0001
602 BLOOD SODIUM DECREASED 1 0.0001
603 FOOT FRACTURE 1 0.0001
604 CONDITION AGGRAVATED 16 0.0001
605 ACUTE KIDNEY INJURY 8 0.0001
606 ORAL HERPES 1 0.0001
607 KIDNEY INFECTION 1 0.0001
608 SINUS DISORDER 1 0.0001
609 BLOOD PRESSURE ABNORMAL 1 0.0001
610 WEIGHT DECREASED 14 0.0001
611 CONFUSIONAL STATE 8 0.0000
612 PRODUCT ADMINISTRATION ERROR 1 0.0000
613 PLEURAL EFFUSION 3 0.0000
614 BONE MARROW FAILURE 1 0.0000
615 LUNG NEOPLASM MALIGNANT 2 0.0000
616 RIB FRACTURE 1 0.0000
617 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
618 DERMATITIS 1 0.0000
619 HALLUCINATION, VISUAL 1 0.0000
620 MYALGIA 8 0.0000
621 EATING DISORDER 1 0.0000
622 IRRITABLE BOWEL SYNDROME 1 0.0000
623 POOR QUALITY SLEEP 1 0.0000
624 SKIN CANCER 1 0.0000
625 FAECES DISCOLOURED 1 0.0000
626 AMNESIA 3 0.0000
627 PRODUCT DISPENSING ERROR 1 0.0000
628 BLOOD PRESSURE DECREASED 3 0.0000
629 RASH MACULO-PAPULAR 1 0.0000
630 INJECTION SITE PRURITUS 3 0.0000
631 RASH PAPULAR 1 0.0000
632 NASOPHARYNGITIS 8 0.0000
633 MUSCLE TWITCHING 1 0.0000
634 SEIZURE 5 0.0000
635 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
636 PERICARDIAL EFFUSION 1 0.0000
637 RENAL DISORDER 2 0.0000
638 ARRHYTHMIA 2 0.0000
639 OCULAR HYPERAEMIA 2 0.0000
640 DISEASE RECURRENCE 2 0.0000
641 MOBILITY DECREASED 3 0.0000
642 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
643 LOCALISED INFECTION 1 0.0000
644 CONSTIPATION 9 0.0000
645 NEURALGIA 1 0.0000
646 MALAISE 18 0.0000
647 CEREBRAL INFARCTION 1 0.0000
648 INJECTION SITE URTICARIA 1 0.0000
649 LIVER INJURY 1 0.0000
650 OSTEONECROSIS OF JAW 1 0.0000
651 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
652 EPISTAXIS 3 0.0000
653 HYPOAESTHESIA 6 0.0000
654 SOMNOLENCE 8 0.0000
655 HAEMATEMESIS 1 0.0000
656 FLUID RETENTION 2 0.0000
657 ERYTHEMA 8 0.0000
658 ILLNESS 4 0.0000
659 INFLAMMATION 2 0.0000
660 UNRESPONSIVE TO STIMULI 1 0.0000
661 HAEMATOMA 1 0.0000
662 DIPLOPIA 1 0.0000
663 MUCOSAL INFLAMMATION 1 0.0000
664 JAUNDICE 1 0.0000
665 CARDIAC ARREST 3 0.0000
666 BLISTER 2 0.0000
667 HYPONATRAEMIA 2 0.0000
668 PAIN IN JAW 1 0.0000
669 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
670 LETHARGY 2 0.0000
671 LIVER FUNCTION TEST ABNORMAL 1 0.0000
672 DYSPHONIA 2 0.0000
673 PAIN 21 0.0000
674 ASCITES 1 0.0000
675 ACUTE MYOCARDIAL INFARCTION 1 0.0000
676 LABORATORY TEST ABNORMAL 1 0.0000
677 PSYCHOTIC DISORDER 1 0.0000
678 CATARACT 2 0.0000
679 APHASIA 1 0.0000
680 STOMATITIS 2 0.0000
681 VERTIGO 2 0.0000
682 EPILEPSY 1 0.0000
683 DRUG-INDUCED LIVER INJURY 1 0.0000
684 HYPOTHYROIDISM 1 0.0000
685 METABOLIC ACIDOSIS 1 0.0000
686 CHOLELITHIASIS 1 0.0000
687 EYE DISORDER 1 0.0000
688 VISUAL ACUITY REDUCED 1 0.0000
689 URINARY RETENTION 1 0.0000
690 EYE PRURITUS 1 0.0000
691 HEPATIC ENZYME INCREASED 2 0.0000
692 HAEMATURIA 1 0.0000
693 NAUSEA 23 0.0000
694 RASH MACULAR 1 0.0000
695 PAIN IN EXTREMITY 8 0.0000
696 DYSGEUSIA 2 0.0000
697 PRODUCT USE ISSUE 5 0.0000
698 DYSARTHRIA 1 0.0000
699 HALLUCINATION 2 0.0000
700 PRURITUS 10 0.0000
701 DISEASE PROGRESSION 3 0.0000
702 INJECTION SITE BRUISING 2 0.0000
703 THROMBOSIS 2 0.0000
704 INFLUENZA LIKE ILLNESS 2 0.0000
705 ARTHRALGIA 10 0.0000
706 COMPLETED SUICIDE 2 0.0000
707 RHABDOMYOLYSIS 1 0.0000
708 ROAD TRAFFIC ACCIDENT 1 0.0000
709 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
710 SKIN IRRITATION 1 0.0000
711 TINNITUS 1 0.0000
712 SWELLING 2 0.0000
713 VOMITING 10 0.0000
714 PULMONARY EMBOLISM 2 0.0000
715 BLOOD GLUCOSE DECREASED 1 0.0000
716 HEADACHE 13 0.0000
717 DYSPEPSIA 2 0.0000
718 CHEST DISCOMFORT 2 0.0000
719 DYSPNOEA 11 0.0000
720 ECZEMA 1 0.0000
721 MUSCULOSKELETAL PAIN 1 0.0000
722 PARAESTHESIA 3 0.0000
723 DISTURBANCE IN ATTENTION 1 0.0000
724 TREATMENT NONCOMPLIANCE 1 0.0000
725 HAEMATOCHEZIA 1 0.0000
726 MEDICATION ERROR 1 0.0000
727 URTICARIA 3 0.0000
728 EYE PAIN 1 0.0000
729 FLATULENCE 1 0.0000
730 EYE IRRITATION 1 0.0000
731 FEELING HOT 1 0.0000
732 CHEST PAIN 3 0.0000
733 HYPERSENSITIVITY 3 0.0000
734 LOSS OF CONSCIOUSNESS 2 0.0000
735 DEHYDRATION 2 0.0000
736 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
737 VISION BLURRED 2 0.0000
738 BURNING SENSATION 1 0.0000
739 INJURY 1 0.0000
740 SLEEP DISORDER 1 0.0000
741 HYPERTENSION 3 0.0000
742 PRODUCT DOSE OMISSION ISSUE 4 0.0000
743 ACNE 1 0.0000
744 DIABETES MELLITUS 1 0.0000
745 INJECTION SITE SWELLING 1 0.0000
746 PERIPHERAL SWELLING 2 0.0000
747 CARDIAC FAILURE CONGESTIVE 1 0.0000
748 ABDOMINAL DISCOMFORT 2 0.0000
749 INTENTIONAL PRODUCT MISUSE 1 0.0000
750 OROPHARYNGEAL PAIN 1 0.0000
751 FLUSHING 1 0.0000
752 INJECTION SITE PAIN 3 0.0000
753 ABDOMINAL PAIN UPPER 2 0.0000
754 ASTHMA 1 0.0000
755 RHEUMATOID ARTHRITIS 1 0.0000
756 JOINT SWELLING 1 0.0000
757 VISUAL IMPAIRMENT 1 0.0000
758 MEMORY IMPAIRMENT 1 0.0000
759 DRUG INTERACTION 1 0.0000
760 DIZZINESS 3 0.0000
761 TOXICITY TO VARIOUS AGENTS 1 0.0000
762 MYOCARDIAL INFARCTION 1 0.0000
763 NO ADVERSE EVENT 1 0.0000
764 MUSCLE SPASMS 1 0.0000
765 ALOPECIA 1 0.0000
766 WEIGHT INCREASED 1 0.0000
767 DEPRESSION 1 0.0000
768 ABDOMINAL PAIN 1 0.0000
769 INSOMNIA 1 0.0000
770 DRUG INEFFECTIVE 1 0.0000